Tocilizumab combination therapy or monotherapy or methotrexate monotherapy in methotrexate-naive patients with early rheumatoid arthritis: 2-year clinical and radiographic results from the randomised, placebo-controlled FUNCTION trial

OBJECTIVE: Investigate whether the efficacy and safety of intravenous tocilizumab (TCZ) demonstrated at week 52 in patients with early rheumatoid arthritis (RA) are maintained to week 104. METHODS: Methotrexate (MTX)-naive patients with early progressive RA were randomly assigned to double-blind 4 m...

Descripción completa

Detalles Bibliográficos
Autores principales: Burmester, Gerd R, Rigby, William F, van Vollenhoven, Ronald F, Kay, Jonathan, Rubbert-Roth, Andrea, Blanco, Ricardo, Kadva, Alysha, Dimonaco, Sophie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2017
Materias:
Clinical and Epidemiological Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5530348/
https://www.ncbi.nlm.nih.gov/pubmed/28389552
http://dx.doi.org/10.1136/annrheumdis-2016-210561

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5530348/
https://www.ncbi.nlm.nih.gov/pubmed/28389552
http://dx.doi.org/10.1136/annrheumdis-2016-210561

Ejemplares similares